All AbMole products are for research use only, cannot be used for human consumption.
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC).
| CAS Number | 216669-97-5 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
[1] Y Xu, et al. Curr Mol Med. Reprograming Carcinoma Associated Fibroblasts by microRNAs
| Related FAP Products |
|---|
| SP-13786
SP-13786 (UAMC-1110) is a novel potent and selective inhibitor of fibroblast activation protein (fap), displaying low nanomolar inhibitory potency and high selectivity against the related dipeptidyl peptidases (dpps) dppiv, dpp9, dppii, and prolyl oligopeptidase (prep). |
| FAPI-4
Feiapi-4 is a fibroblast activating protein (FAP) inhibitor that can be used in cancer research. |
| FAP-IN-2
FAP-IN-2 is a derivative of 99mTc-labeled isonitrile-containing fibroblast activation protein (FAPI) inhibitor, that can be used for tumor imaging. |
| FAP-IN-2 TFA
FAP-IN-2 TFA is a 99mTc-labeled isonitrile-containing FAP inhibitor derivative that can be used for tumor imaging. |
| FAPI-74
FAPI-74 is a PET (positron emission tomography) tracer targeting the fibroblast activation protein (FAP). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
